Life Sciences Companies From The US, Europe, And Japan Gather At ClearTrial's 3rd Annual User Group Meeting
Several customers present case studies, sharing their best practices using ClearTrial software to enable greater clinical development efficiency
ClearTrial, the leading provider of software for the planning, forecasting, and tracking of clinical project and financial performance, announced recently that the company held its highly successful User Group meeting October 17-19, 2011 in Las Vegas, Nevada. This 3rd annual meeting drew representatives from small, mid-size, and Top 20 biopharmaceutical and medical device companies from around the world. Attendees were treated to a dynamic and informative event which included ClearTrial software case studies provided by their peers, interactive breakout sessions, advanced training, and plenty of formal and informal networking opportunities.
As one attendee said afterward: "This was the best software User Group conference I have ever been to in terms of the most useful information for users, interaction with other users, level of detail presented and in terms of user concern."
The User Group meeting actively fostered an environment conducive to a free interchange of knowledge and ideas. As just one example, several ClearTrial customers presented detailed case studies of their use of ClearTrial software, sharing lessons learned, best practices, and results. Among other benefits, these customers pointed to the ability of ClearTrial software to help them conduct accurate, long-range study cost and resource forecasting, enable more effective preferred provider relationships, and maintain alignment with fast-paced corporate financial processes.
Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, opened the meeting with an insightful keynote address, "Transforming Legacy R&D Through Open Innovation." He presented a compelling argument for moving R&D efforts to open and integrated communities, noting successes such as Developer-Patient Partnerships, Public-Private Partnerships, and Integrated Alliances. Tufts CSDD research indicates that the number of open innovation partnerships — including public-private partnerships and integrated pharmaceutical development alliances — has been rising sharply during the past several years, most notably those involving top 30 pharmaceutical and biotechnology companies.
"We were pleased to have hosted so many of our customers at this year's User Group meeting," noted Andrew Grygiel, Chief Marketing Officer for ClearTrial. "These are companies whose products are saving lives and making lives better, and we're honored that ClearTrial software plays a role in helping them bring these products to market more quickly and cost-effectively."
About ClearTrial
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, linking clinical planning, forecasting, and tracking of operational and financial performance in a single, integrated system. ClearTrial's award-winning software helps life sciences companies streamline their clinical operations from Plan to Payment without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information, visit http://www.cleartrial.com.
SOURCE: ClearTrial